14
Participants
Start Date
October 31, 2011
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
rAAV2.REP1
Single subretinal injection of rAAV2.REP1 vector suspension containing 10e12 genome particles per ml. Dose 1 = dose containing approximately 10e10 rAAV2.REP1 genome particles. Dose 2 = dose containing approximately 10e11 rAAV2.REP1 genome particles.
Moorfields Eye Hospital NHS Foundation Trust, London
St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester
Oxford Radcliffe Hospitals NHS Trust, Oxford
Eye Unit, Southampton University Hospitals NHS Trust, Southampton
Oxford University Hospitals NHS Trust
OTHER
Moorfields Eye Hospital NHS Foundation Trust
OTHER
University College, London
OTHER
Manchester University NHS Foundation Trust
OTHER_GOV
University of Manchester
OTHER
University Hospital Southampton NHS Foundation Trust
OTHER
University of Southampton
OTHER
University of Oxford
OTHER